BioCentury | Apr 1, 2020
Finance

Reversing course on IPO plans, iTeos draws $125M in private round with crossovers

...Also participating were existing investors MPM Capital, HBM Partners, 6 Dimensions Capital, Curative Ventures, Fund+, VIVES Louvain Technology Fund...
BioCentury | May 24, 2019
Finance

How Europe’s hotspots of innovation could fuel its rise as a global player in new modalities

...iTeos Therapeutics S.A. $75.0 Series B HBM Partners, 6 Dimensions Capital, Curative Ventures, SFPI-FPIM, Fund+, Vives Louvain Technology Fund...
BioCentury | Jun 22, 2018
Financial News

Oncology play iTeos raises $75M, outlines clinical plans

...HBM Partners, 6 Dimensions Capital, Curative Ventures and SFPI as well as existing investors Fund+, Vives Louvain Technology Fund...
BioCentury | Jun 20, 2018
Financial News

Oncology play iTeos raises $75M, outlines clinical plans

...HBM Partners, 6 Dimensions Capital, Curative Ventures and SFPI as well as existing investors Fund+, Vives Louvain Technology Fund...
BioCentury | Jun 20, 2018
Finance

Iterating iTeos

...HBM Partners, 6 Dimensions Capital, Curative Ventures and SFPI as well as existing investors Fund+, Vives Louvain Technology Fund...
BioCentury | Mar 29, 2018
Emerging Company Profile

Strengthening synapses

...Johnson & Johnson Innovation - JJDC Inc., V-BIO Ventures, the Walloon Investment Fund (SRIW) and VIVES Louvain Technology Fund...
BioCentury | Feb 2, 2018
Financial News

UCB spinout Syndesi raises €17M series A

...with participation from Johnson and Johnson innovation, V-BIO ventures, the Walloon Investment Fund (SRIW) and VIVES Louvain Technology fund...
BioCentury | May 19, 2016
Finance

Found in translation

...musculoskeletal Epimede; Fund+; Integrale; New Science Ventures; Nivelinvest; SFPI-FPIM; Société Régionale d'Investissement de Wallonie S.A.; Vives Louvain Technology Fund...
BioCentury | Sep 14, 2015
Financial News

Novadip completes venture financing

...Date completed: 2015-09-10 Type: Venture financing Raised: EUR28 million ($31.2 million) Investors: New Science Ventures; Vives Louvain Technology Fund...
BioCentury | Sep 11, 2015
Financial News

Novadip raises EUR 28M in series A

...$31.2 million) in a series A round led by New Science Ventures. Also participating were VIVES Louvain Technology Fund...
Items per page:
1 - 10 of 15
BioCentury | Apr 1, 2020
Finance

Reversing course on IPO plans, iTeos draws $125M in private round with crossovers

...Also participating were existing investors MPM Capital, HBM Partners, 6 Dimensions Capital, Curative Ventures, Fund+, VIVES Louvain Technology Fund...
BioCentury | May 24, 2019
Finance

How Europe’s hotspots of innovation could fuel its rise as a global player in new modalities

...iTeos Therapeutics S.A. $75.0 Series B HBM Partners, 6 Dimensions Capital, Curative Ventures, SFPI-FPIM, Fund+, Vives Louvain Technology Fund...
BioCentury | Jun 22, 2018
Financial News

Oncology play iTeos raises $75M, outlines clinical plans

...HBM Partners, 6 Dimensions Capital, Curative Ventures and SFPI as well as existing investors Fund+, Vives Louvain Technology Fund...
BioCentury | Jun 20, 2018
Financial News

Oncology play iTeos raises $75M, outlines clinical plans

...HBM Partners, 6 Dimensions Capital, Curative Ventures and SFPI as well as existing investors Fund+, Vives Louvain Technology Fund...
BioCentury | Jun 20, 2018
Finance

Iterating iTeos

...HBM Partners, 6 Dimensions Capital, Curative Ventures and SFPI as well as existing investors Fund+, Vives Louvain Technology Fund...
BioCentury | Mar 29, 2018
Emerging Company Profile

Strengthening synapses

...Johnson & Johnson Innovation - JJDC Inc., V-BIO Ventures, the Walloon Investment Fund (SRIW) and VIVES Louvain Technology Fund...
BioCentury | Feb 2, 2018
Financial News

UCB spinout Syndesi raises €17M series A

...with participation from Johnson and Johnson innovation, V-BIO ventures, the Walloon Investment Fund (SRIW) and VIVES Louvain Technology fund...
BioCentury | May 19, 2016
Finance

Found in translation

...musculoskeletal Epimede; Fund+; Integrale; New Science Ventures; Nivelinvest; SFPI-FPIM; Société Régionale d'Investissement de Wallonie S.A.; Vives Louvain Technology Fund...
BioCentury | Sep 14, 2015
Financial News

Novadip completes venture financing

...Date completed: 2015-09-10 Type: Venture financing Raised: EUR28 million ($31.2 million) Investors: New Science Ventures; Vives Louvain Technology Fund...
BioCentury | Sep 11, 2015
Financial News

Novadip raises EUR 28M in series A

...$31.2 million) in a series A round led by New Science Ventures. Also participating were VIVES Louvain Technology Fund...
Items per page:
1 - 10 of 15